Cardiovascular magnetic resonance imaging provides complementary information to echocardiography for assessing mitral regurgitation severity and planning intervention, prompting standardized protocols.
This consensus statement provides standardized protocols and reporting guidelines for using cardiovascular magnetic resonance imaging to assess mitral regurgitation.
Mitral regurgitation (MR) is a common valvular heart disease and is the second most frequent indication for heart valve surgery in Western countries. Echocardiography is the recommended first-line test for the assessment of valvular heart disease, but cardiovascular magnetic resonance imaging (CMR) provides complementary information, especially for assessing MR severity and to plan the timing of intervention. As new CMR techniques for the assessment of MR have arisen, standardizing CMR protocols for research and clinical studies has become important in order to optimize diagnostic utility and support the wider use of CMR for the clinical assessment of MR. In this Consensus Statement, we provide a detailed description of the current evidence on the use of CMR for MR assessment, highlight its current clinical utility, and recommend a standardized CMR protocol and report for MR assessment.
Garg et al. (Mon,) conducted a review in Mitral regurgitation. Cardiovascular magnetic resonance imaging (CMR) vs. Echocardiography was evaluated. Cardiovascular magnetic resonance imaging provides complementary information to echocardiography for assessing mitral regurgitation severity and planning intervention, prompting standardized protocols.